{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:56:08Z","timestamp":1784948168232,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s13760-023-02441-5","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T05:39:11Z","timestamp":1706593151000},"page":"879-885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum level of YWHAG as a diagnostic marker of cognitive impairment in Parkinson\u2019s disease patients"],"prefix":"10.1007","volume":"124","author":[{"given":"Yingying","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6982-4752","authenticated-orcid":false,"given":"Qingling","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"2441_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7:47","journal-title":"Nat Rev Dis Primers"},{"key":"2441_CR2","doi-asserted-by":"publisher","first-page":"117177","DOI":"10.1016\/j.jns.2020.117177","volume":"419","author":"PRP Brand\u00e3o","year":"2020","unstructured":"Brand\u00e3o PRP, Munhoz RP, Grippe TC, Cardoso FEC, e Castro BM, Titze-de-Almeida R, Tomaz C, Tavares MCH (2020) Cognitive impairment in Parkinson\u2019s disease: a clinical and pathophysiological overview. J Neurol Sci 419:117177","journal-title":"J Neurol Sci"},{"key":"2441_CR3","first-page":"S40","volume":"14","author":"D Weintraub","year":"2008","unstructured":"Weintraub D, Comella CL, Horn S (2008) Parkinson\u2019s disease\u2013Part 1: pathophysiology, symptoms, burden, diagnosis, and assessment. Am J Manag Care 14:S40\u2013S48","journal-title":"Am J Manag Care"},{"key":"2441_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","volume":"11","author":"P Svenningsson","year":"2012","unstructured":"Svenningsson P, Westman E, Ballard C, Aarsland D (2012) Cognitive impairment in patients with Parkinson\u2019s disease: diagnosis, biomarkers, and treatment. Lancet Neurol 11:697\u2013707","journal-title":"Lancet Neurol"},{"key":"2441_CR5","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3390\/life11111239","volume":"11","author":"T-S Fan","year":"2021","unstructured":"Fan T-S, Liu SC-H, Wu R-M (2021) Alpha-synuclein and cognitive decline in Parkinson disease. Life 11:1239","journal-title":"Life"},{"key":"2441_CR6","doi-asserted-by":"publisher","first-page":"1900177","DOI":"10.1002\/ardp.201900177","volume":"352","author":"B Mathew","year":"2019","unstructured":"Mathew B, Parambi DG, Mathew GE, Uddin MS, Inasu ST, Kim H, Marathakam A, Unnikrishnan MK, Carradori S (2019) Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer\u2019s and Parkinson\u2019s diseases. Arch Pharm 352:1900177","journal-title":"Arch Pharm"},{"key":"2441_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s12033-022-00613-x","volume":"65","author":"L Han","year":"2023","unstructured":"Han L, Tang J, Zhu S, Zhu J (2023) LncRNA SNHG7 knockdown aggravates hepatic ischemia-reperfusion injury and promotes apoptosis in hemorrhagic shock pregnant rats by modulating miR-34a-5p\/YWHAG Axis. Mol Biotechnol 65:983\u2013996","journal-title":"Mol Biotechnol"},{"key":"2441_CR8","doi-asserted-by":"publisher","first-page":"106848","DOI":"10.1016\/j.yebeh.2019.106848","volume":"104","author":"L Zhu","year":"2020","unstructured":"Zhu L, Chen L, Xu P, Lu D, Dai S, Zhong L, Han Y, Zhang M, Xiao B, Chang L (2020) Genetic and molecular basis of epilepsy-related cognitive dysfunction. Epilepsy Behav 104:106848","journal-title":"Epilepsy Behav"},{"key":"2441_CR9","doi-asserted-by":"publisher","first-page":"632466","DOI":"10.3389\/fgene.2021.632466","volume":"12","author":"X-G Ye","year":"2021","unstructured":"Ye X-G, Liu Z-G, Wang J, Dai J-M, Qiao P-X, Gao P-M, Liao W-P (2021) YWHAG mutations cause childhood myoclonic epilepsy and febrile seizures: molecular sub-regional effect and mechanism. Front Genet 12:632466","journal-title":"Front Genet"},{"key":"2441_CR10","doi-asserted-by":"publisher","unstructured":"Yanmei G, Daijun W, Xiaomei L, Yingying W, Meixia D, Li Y (2022) YWHAG promotes gastric cancer proliferation and migration via PI3K\/AKT pathway. https:\/\/doi.org\/10.21203\/rs.3.rs-1402042\/v1","DOI":"10.21203\/rs.3.rs-1402042\/v1"},{"key":"2441_CR11","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/mds.28779","volume":"36","author":"WW Aamodt","year":"2021","unstructured":"Aamodt WW, Waligorska T, Shen J, Tropea TF, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Xie SX (2021) Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease. Mov Disord 36:2945\u20132950","journal-title":"Mov Disord"},{"key":"2441_CR12","doi-asserted-by":"publisher","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","volume":"93","author":"C-H Lin","year":"2019","unstructured":"Lin C-H, Li C-H, Yang K-C, Lin F-J, Wu C-C, Chieh J-J, Chiu M-J (2019) Blood NfL: a biomarker for disease severity and progression in Parkinson disease. Neurology 93:e1104\u2013e1111","journal-title":"Neurology"},{"key":"2441_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ajhg.2010.10.019","volume":"87","author":"MB Ramocki","year":"2010","unstructured":"Ramocki MB, Bartnik M, Szafranski P, Ko\u0142odziejska KE, Xia Z, Bravo J, Miller GS, Rodriguez DL, Williams CA, Bader PI (2010) Recurrent distal 7q11. 23 deletion including HIP1 and YWHAG identified in patients with intellectual disabilities, epilepsy, and neurobehavioral problems. Am J Hum Genet 87:857\u2013865","journal-title":"Am J Hum Genet"},{"key":"2441_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-023-00440-5","volume":"20","author":"S Weiner","year":"2023","unstructured":"Weiner S, Junkkari A, Sauer M, Luikku A, Rauramaa T, Kokkola T, Herukka S-K, Blennow K, Zetterberg H, Leinonen V (2023) Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus. Fluids Barriers CNS 20:1\u201316","journal-title":"Fluids Barriers CNS"},{"key":"2441_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201800105","author":"G Sathe","year":"2019","unstructured":"Sathe G, Na CH, Renuse S, Madugundu AK, Albert M, Moghekar A, Pandey A (2019) Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer\u2019s disease. Proteomics Clin Appl. https:\/\/doi.org\/10.1002\/prca.201800105","journal-title":"Proteomics Clin Appl"},{"key":"2441_CR16","doi-asserted-by":"publisher","first-page":"137219","DOI":"10.1016\/j.neulet.2023.137219","volume":"804","author":"L Dong","year":"2023","unstructured":"Dong L, Chang Q, Ma J, Liu C, Guo D, Li X, Yang D, Fan Y, Liang K, Li D (2023) Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson\u2019s disease patients. Neurosci Lett 804:137219","journal-title":"Neurosci Lett"},{"key":"2441_CR17","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrneurol.2014.205","volume":"10","author":"M Politis","year":"2014","unstructured":"Politis M (2014) Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol 10:708\u2013722","journal-title":"Nat Rev Neurol"},{"key":"2441_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6169-0","volume":"20","author":"P Liu","year":"2020","unstructured":"Liu P, Kong L, Liang K, Wu Y, Jin H, Song B, Tan X (2020) Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach. BMC Cancer 20:1\u20139","journal-title":"BMC Cancer"},{"key":"2441_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-020-00385-5","volume":"15","author":"ASL Ng","year":"2020","unstructured":"Ng ASL, Tan YJ, Yong ACW, Saffari SE, Lu Z, Ng EY, Ng SYE, Chia NSY, Choi X, Heng D (2020) Utility of plasma neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson\u2019s disease. Mol Neurodegener 15:1\u20138","journal-title":"Mol Neurodegener"},{"key":"2441_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/mds.28909","volume":"37","author":"C Buhmann","year":"2022","unstructured":"Buhmann C, Lezius S, P\u00f6tter-Nerger M, Gerloff C, Kuhle J, Choe Cu (2022) Age-adjusted serum neurofilament predicts cognitive decline in Parkinson\u2019s disease (MARK-PD). Mov Disord 37:435\u2013436","journal-title":"Mov Disord"},{"key":"2441_CR21","doi-asserted-by":"publisher","first-page":"9174","DOI":"10.1080\/21655979.2021.1995115","volume":"12","author":"X Zhou","year":"2021","unstructured":"Zhou X, Wang Z, Xu B, Ji N, Meng P, Gu L, Li Y (2021) Long non-coding RNA NORAD protects against cerebral ischemia\/reperfusion injury induced brain damage, cell apoptosis, oxidative stress and inflammation by regulating miR-30a-5p\/YWHAG. Bioengineered 12:9174\u20139188","journal-title":"Bioengineered"},{"key":"2441_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/ajmg.a.61483","volume":"182","author":"F Kanani","year":"2020","unstructured":"Kanani F, Titheradge H, Cooper N, Elmslie F, Lees MM, Juusola J, Pisani L, McKenna C, Mignot C, Valence S (2020) Expanding the genotype\u2013phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy. Am J Med Genet A 182:713\u2013720","journal-title":"Am J Med Genet A"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-023-02441-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T16:21:09Z","timestamp":1717086069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-023-02441-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2441"],"URL":"https:\/\/doi.org\/10.1007\/s13760-023-02441-5","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]},"assertion":[{"value":"23 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared that they had no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}